On September 7, 2021 Istari Oncology, Inc., a clinical-stage biotechnology company focused on novel immunotherapies for the treatment of solid tumors, reported the company will participate in the following two virtual investment conferences taking place in September 2021 (Press release, Istari Oncology, SEP 7, 2021, View Source [SID1234587327]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: Morgan Stanley’s 19th Annual Global Healthcare Conference
Speaker: Executive leadership, Istari Oncology
Session Date/Time: Tuesday, September 14, 2021, from 5:00 – 5:30 p.m. EDT
Format: Fireside chat
Registration: Interested parties can attend the live webcast of Istari’s fireside chat here. The webcast will also be archived on www.istarioncology.com.

Event: H.C. Wainwright 23rd Annual Global Investment Conference
Speaker: Garrett Nichols, CMO, Istari Oncology
Session Date/Time: Available on-demand from September 13-15, 2021, beginning at 7:00 a.m. EDT
Format: Company presentation
Registration: Institutional investors can register for the conference and view Istari’s on-demand presentation here.